← runs
LLY
ELI LILLY & Coeval runfigures
| field | value | statement row | printed | SEC |
|---|---|---|---|---|
| Total revenue | $65.2B | R2 Revenue | 65,179 millions | $65.2B ✓ |
| Operating income | - | not printed on this statement | - | - |
| Net income attributable to the company | $20.6B | R13 Net income | 20,640 millions | $20.6B ✓ |
| Diluted EPS | $22.95 | R16 Diluted | 22.95 | $22.95 ✓ |
| Cash and cash equivalents | $7.3B | R4 Cash and cash equivalents | 7,268 millions | $7.3B ✓ |
| Total assets | $112.5B | R18 Total assets | 112,476 millions | $112.5B ✓ |
| Total liabilities | - | not printed on this statement | - | - |
| Total shareholders' equity attributable to the company | $26.5B | R40 Total equity | 26,535 millions | $26.5B ✓ |
| Net cash from operating activities | $16.8B | R16 Net Cash Provided by Operating Activities | 16,813 millions | $16.8B ✓ |
| Net cash from investing activities | -$11.0B | R25 Net Cash Used for Investing Activities | (10,972) millions | -$11.0B ✓ |
| Net cash from financing activities | -$2.2B | R33 Net Cash Provided by (Used for) Financing Activities | (2,213) millions | -$2.2B ✓ |
checks
- assets = liabilities + equity · total assets equals total liabilities and equity
- equity excludes minority interests · not applicable: no noncontrolling interest line printed
- net income is before preferred dividends · net income is not the after-preferred-dividends line
- diluted EPS is for total net income · diluted EPS is for total net income
- net income excludes minority interests · not applicable: no noncontrolling interest line printed
- cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash
management's claims
All 2 checkable claims in management's discussion match the statements.
- matchesCash and cash equivalents: "Cash and cash equivalents" is 7268000000 (prior year 3268000000)
“Cash and cash equivalents increased to $7.3 billion as of December 31, 2025, compared with $3.3 billion at December 31, 2024.”
- matchesNet cash from operating activities: "Net Cash Provided by Operating Activities" is 16813000000 (prior year 8818000000)
“Net cash provided by operating activities increased to $16.8 billion in 2025, compared with $8.8 billion in 2024.”
trace
0locator (code)0.13s
{ "tables": 78, "exhibits": [], "documents": 1 }{ "income": { "rows": 20, "scale": 1000000, "score": 49, "heading": " Statements of Operations ELI LILLY AND COMPANY AND SUBSIDIARIES (Dollars and shares in millions, except per-share data)", "tableIndex": 21, "runnerUpScore": 26.25 }, "balance": { "rows": 42, "scale": 1000000, "score": 53.25, "heading": "ncial statements. 58 Consolidated Balance Sheets ELI LILLY AND COMPANY AND SUBSIDIARIES (Dollars and shares in millions)", "tableIndex": 23, "runnerUpScore": 20.75 }, "cashflow": { "rows": 38, "scale": 1000000, "score": 53, "heading": "ancial statements. 60 Consolidated Statements of Cash Flows ELI LILLY AND COMPANY AND SUBSIDIARIES (Dollars in millions)", "tableIndex": 25, "runnerUpScore": 8.25 } }1cash flow agent1.54s · 1510 tokens · $0.0002
{ "rows": 38, "retryHint": null, "tableIndex": 25 }{ "figures": [ { "note": "This is the operating activities section total after the working-capital changes.", "field": "operatingCashFlow", "scale": 1000000, "value": 16813000000, "printed": "16,813", "rowIndex": 16, "rowLabel": "Net Cash Provided by Operating Activities", "priorValue": 8818000000, "agentPrinted": "16,813", "failedChecks": [], "priorPrinted": "8,818", "groundingMismatch": false }, { "note": "This is the investing activities section total.", "field": "investingCashFlow", "scale": 1000000, "value": -10972000000, "printed": "(10,972)", "rowIndex": 25, "rowLabel": "Net Cash Used for Investing Activities", "priorValue": -9302000000, "agentPrinted": "(10,972)", "failedChecks": [], "priorPrinted": "(9,302)", "groundingMismatch": false }, { "note": "This is the financing activities section total.", "field": "financingCashFlow", "scale": 1000000, "value": -2213000000, "printed": "(2,213)", "rowIndex": 33, "rowLabel": "Net Cash Provided by (Used for) Financing Activities", "priorValue": 1230000000, "agentPrinted": "(2,213)", "failedChecks": [], "priorPrinted": "1,230", "groundingMismatch": false } ], "statement": "cashflow", "tableIndex": 25, "priorColumn": 1, "currentColumn": 0 }2income statement agent1.72s · 1363 tokens · $0.0002
{ "rows": 20, "retryHint": null, "tableIndex": 21 }{ "figures": [ { "note": "Revenue is the single company-wide revenue line printed.", "field": "revenue", "scale": 1000000, "value": 65179000000, "printed": "65,179", "rowIndex": 2, "rowLabel": "Revenue", "priorValue": 45043000000, "agentPrinted": "65,179", "failedChecks": [], "priorPrinted": "45,043", "groundingMismatch": false }, { "note": "The statement does not label an operating income line; the unlabeled expense total is not explicitly identified as operating income.", "field": "operatingIncome", "scale": 1000000, "value": null, "printed": null, "rowIndex": null, "rowLabel": null, "priorValue": null, "agentPrinted": null, "failedChecks": [], "priorPrinted": null, "groundingMismatch": false }, { "note": "Net income is the only net income line, with no separate noncontrolling-interest attribution line.", "field": "netIncome", "scale": 1000000, "value": 20640000000, "printed": "20,640", "rowIndex": 13, "rowLabel": "Net income", "priorValue": 10590000000, "agentPrinted": "20,640", "failedChecks": [], "priorPrinted": "10,590", "groundingMismatch": false }, { "note": "This is the diluted earnings-per-share figure.", "field": "epsDiluted", "scale": 1, "value": 22.95, "printed": "22.95", "rowIndex": 16, "rowLabel": "Diluted", "priorValue": 11.71, "agentPrinted": "22.95", "failedChecks": [], "priorPrinted": "11.71", "groundingMismatch": false } ], "statement": "income", "tableIndex": 21, "priorColumn": 1, "currentColumn": 0 }3balance sheet agent1.81s · 1390 tokens · $0.0002
{ "rows": 42, "retryHint": null, "tableIndex": 23 }{ "figures": [ { "note": "This is the cash and cash equivalents line.", "field": "cash", "scale": 1000000, "value": 7268000000, "printed": "7,268", "rowIndex": 4, "rowLabel": "Cash and cash equivalents", "priorValue": 3268000000, "agentPrinted": "7,268", "failedChecks": [], "priorPrinted": "3,268", "groundingMismatch": false }, { "note": "This is the printed total assets line.", "field": "totalAssets", "scale": 1000000, "value": 112476000000, "printed": "112,476", "rowIndex": 18, "rowLabel": "Total assets", "priorValue": 78715000000, "agentPrinted": "112,476", "failedChecks": [], "priorPrinted": "78,715", "groundingMismatch": false }, { "note": "The statement does not print a total liabilities line.", "field": "totalLiabilities", "scale": 1000000, "value": null, "printed": null, "rowIndex": null, "rowLabel": null, "priorValue": null, "agentPrinted": null, "failedChecks": [], "priorPrinted": null, "groundingMismatch": false }, { "note": "This is the only printed equity total.", "field": "totalEquity", "scale": 1000000, "value": 26535000000, "printed": "26,535", "rowIndex": 40, "rowLabel": "Total equity", "priorValue": 14272000000, "agentPrinted": "26,535", "failedChecks": [], "priorPrinted": "14,272", "groundingMismatch": false } ], "statement": "balance", "tableIndex": 23, "priorColumn": 1, "currentColumn": 0 }4reconciler (code)0.00s
null
[ { "name": "balance_identity", "detail": "total assets equals total liabilities and equity", "fields": [ "totalAssets" ], "passed": true, "skipped": false, "statement": "balance" }, { "name": "totalEquity_attribution", "detail": "no noncontrolling interest line printed", "fields": [ "totalEquity" ], "passed": true, "skipped": true, "statement": "balance" }, { "name": "netIncome_before_preferred", "detail": "net income is not the after-preferred-dividends line", "fields": [ "netIncome" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "epsDiluted_total", "detail": "diluted EPS is for total net income", "fields": [ "epsDiluted" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "netIncome_attribution", "detail": "no noncontrolling interest line printed", "fields": [ "netIncome" ], "passed": true, "skipped": true, "statement": "income" }, { "name": "cash_flow_tie", "detail": "operating + investing + financing (+ FX) equals the net change in cash", "fields": [ "operatingCashFlow", "investingCashFlow", "financingCashFlow" ], "passed": true, "skipped": false, "statement": "cashflow" } ]5MD&A claims agent1.62s · 1471 tokens · $0.0002
null
[ { "kind": "current_value", "field": "cash", "quote": "Cash and cash equivalents increased to $7.3 billion as of December 31, 2025, compared with $3.3 billion at December 31, 2024.", "scope": "consolidated", "actual": 7268000000, "reason": "Cash and cash equivalents: \"Cash and cash equivalents\" is 7268000000 (prior year 3268000000)", "claimed": 7300000000, "verdict": "consistent", "asWritten": "$7.3 billion", "tolerance": 50000000, "quoteVerified": true }, { "kind": "current_value", "field": "operatingCashFlow", "quote": "Net cash provided by operating activities increased to $16.8 billion in 2025, compared with $8.8 billion in 2024.", "scope": "consolidated", "actual": 16813000000, "reason": "Net cash from operating activities: \"Net Cash Provided by Operating Activities\" is 16813000000 (prior year 8818000000)", "claimed": 16800000000, "verdict": "consistent", "asWritten": "$16.8 billion", "tolerance": 50000000, "quoteVerified": true } ]
Income statement
table #21 · current period is figure column 1| 0 | Year Ended December 31, | |||
| 1 | 2025 | 2024 | 2023 | |
| 2 | Revenue← Total revenue | 65,179 | 45,043 | 34,124 |
| 3 | Costs, expenses, and other: | |||
| 4 | Cost of sales | 11,052 | 8,418 | 7,082 |
| 5 | Research and development | 13,337 | 10,991 | 9,313 |
| 6 | Marketing, selling, and administrative | 11,094 | 8,594 | 7,404 |
| 7 | Acquired in-process research and development | 2,910 | 3,280 | 3,800 |
| 8 | Asset impairment, restructuring, and other special charges | 484 | 861 | 68 |
| 9 | Other-net, (income) expense | 571 | 219 | (97) |
| 10 | 39,448 | 32,363 | 27,570 | |
| 11 | Income before income taxes | 25,731 | 12,680 | 6,554 |
| 12 | Income taxes | 5,091 | 2,090 | 1,314 |
| 13 | Net income← Net income attributable to the company | 20,640 | 10,590 | 5,240 |
| 14 | Earnings per share: | |||
| 15 | Basic | 23.00 | 11.76 | 5.82 |
| 16 | Diluted← Diluted EPS | 22.95 | 11.71 | 5.80 |
| 17 | Shares used in calculation of earnings per share: | |||
| 18 | Basic | 897.3 | 900.6 | 900.2 |
| 19 | Diluted | 899.3 | 904.1 | 903.3 |
Balance sheet
table #23 · current period is figure column 1| 0 | December 31, | ||
| 1 | 2025 | 2024 | |
| 2 | Assets | ||
| 3 | Current Assets | ||
| 4 | Cash and cash equivalents← Cash and cash equivalents | 7,268 | 3,268 |
| 5 | Accounts receivable | 17,760 | 11,006 |
| 6 | Other receivables | 2,395 | 2,270 |
| 7 | Inventories | 13,744 | 7,589 |
| 8 | Prepaid expenses | 14,315 | 8,341 |
| 9 | Other current assets | 147 | 266 |
| 10 | Total current assets | 55,629 | 32,740 |
| 11 | Noncurrent Assets | ||
| 12 | Investments | 2,802 | 3,216 |
| 13 | Goodwill | 5,898 | 5,770 |
| 14 | Other intangibles, net | 6,521 | 6,166 |
| 15 | Deferred tax assets | 9,959 | 8,001 |
| 16 | Property and equipment, net | 24,675 | 17,102 |
| 17 | Other noncurrent assets | 6,992 | 5,720 |
| 18 | Total assets← Total assets | 112,476 | 78,715 |
| 19 | Liabilities and Equity | ||
| 20 | Current Liabilities | ||
| 21 | Short-term borrowings and current maturities of long-term debt | 1,635 | 5,117 |
| 22 | Accounts payable | 5,379 | 3,229 |
| 23 | Employee compensation | 2,375 | 2,094 |
| 24 | Sales rebates and discounts | 17,382 | 11,539 |
| 25 | Other current liabilities | 8,457 | 6,397 |
| 26 | Total current liabilities | 35,228 | 28,376 |
| 27 | Noncurrent Liabilities | ||
| 28 | Long-term debt | 40,868 | 28,527 |
| 29 | Long-term income taxes payable | 5,875 | 4,061 |
| 30 | Other noncurrent liabilities | 3,970 | 3,479 |
| 31 | Total noncurrent liabilities | 50,713 | 36,067 |
| 32 | Commitments and Contingencies | ||
| 33 | Equity | ||
| 34 | Common stock-no par valueAuthorized shares: 3,200.0Issued shares: 944.8 (2025) and 947.9 (2024) | 590 | 592 |
| 35 | Additional paid-in capital | 7,346 | 7,439 |
| 36 | Retained earnings | 24,470 | 13,545 |
| 37 | Employee benefit trust | (3,013) | (3,013) |
| 38 | Accumulated other comprehensive loss | (2,880) | (4,322) |
| 39 | Other equity | 22 | 31 |
| 40 | Total equity← Total shareholders' equity attributable to the company | 26,535 | 14,272 |
| 41 | Total liabilities and equity | 112,476 | 78,715 |
Cash flow statement
table #25 · current period is figure column 1| 0 | Year Ended December 31, | |||
| 1 | 2025 | 2024 | 2023 | |
| 2 | Cash Flows from Operating Activities | |||
| 3 | Net income | 20,640 | 10,590 | 5,240 |
| 4 | Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: | |||
| 5 | Depreciation and amortization | 1,997 | 1,767 | 1,527 |
| 6 | Change in deferred income taxes | (1,707) | (2,683) | (2,341) |
| 7 | Stock-based compensation expense | 626 | 646 | 629 |
| 8 | Gains on sale of product rights | (180) | (224) | (1,879) |
| 9 | Acquired in-process research and development | 2,910 | 3,280 | 3,800 |
| 10 | Other operating activities, net | 620 | 826 | 319 |
| 11 | Other changes in operating assets and liabilities, net of acquisitions and divestitures: | |||
| 12 | Receivables-(increase) decrease | (7,000) | (2,155) | (2,451) |
| 13 | Inventories-(increase) decrease | (4,671) | (2,507) | (1,425) |
| 14 | Prepaid expenses and other assets-(increase) decrease | (6,609) | (3,331) | (3,453) |
| 15 | Accounts payable and other liabilities-increase (decrease) | 10,187 | 2,609 | 4,274 |
| 16 | Net Cash Provided by Operating Activities← Net cash from operating activities | 16,813 | 8,818 | 4,240 |
| 17 | Cash Flows from Investing Activities | |||
| 18 | Purchases of property and equipment | (7,841) | (5,058) | (3,448) |
| 19 | Proceeds from sales of and distributions from noncurrent investments | 964 | 374 | 508 |
| 20 | Purchases of noncurrent investments | (645) | (677) | (731) |
| 21 | Proceeds from sale of product rights | 218 | 601 | 1,604 |
| 22 | Purchases of in-process research and development | (3,008) | (3,346) | (3,944) |
| 23 | Cash paid for acquisitions, net of cash acquired | (661) | (948) | (1,044) |
| 24 | Other investing activities, net | 1 | (248) | (98) |
| 25 | Net Cash Used for Investing Activities← Net cash from investing activities | (10,972) | (9,302) | (7,153) |
| 26 | Cash Flows from Financing Activities | |||
| 27 | Dividends paid | (5,384) | (4,680) | (4,069) |
| 28 | Net change in short-term borrowings | (4,338) | (1,852) | 4,691 |
| 29 | Proceeds from issuance of long-term debt | 13,167 | 11,417 | 3,959 |
| 30 | Repayments of long-term debt | (778) | (664) | - |
| 31 | Purchases of common stock | (4,108) | (2,500) | (750) |
| 32 | Other financing activities, net | (772) | (491) | (335) |
| 33 | Net Cash Provided by (Used for) Financing Activities← Net cash from financing activities | (2,213) | 1,230 | 3,496 |
| 34 | Effect of exchange rate changes on cash and cash equivalents | 372 | (297) | 169 |
| 35 | Net increase in cash and cash equivalents | 4,000 | 449 | 752 |
| 36 | Cash and cash equivalents at beginning of year | 3,268 | 2,819 | 2,067 |
| 37 | Cash and Cash Equivalents at End of Year | 7,268 | 3,268 | 2,819 |